Orion Pharma (DHA:ORIONPHARM) Cash-to-Debt : 0.01 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Orion Pharma's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.01.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Orion Pharma couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Orion Pharma's Cash-to-Debt or its related term are showing as below:

DHA:ORIONPHARM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: 0.04 Max: 0.16
Current: 0.01

During the past 11 years, Orion Pharma's highest Cash to Debt Ratio was 0.16. The lowest was 0.01. And the median was 0.04.

DHA:ORIONPHARM's Cash-to-Debt is ranked worse than
97.89% of 427 companies
in the Utilities - Independent Power Producers industry
Industry Median: 0.22 vs DHA:ORIONPHARM: 0.01

Orion Pharma Cash-to-Debt Historical Data

The historical data trend for Orion Pharma's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Orion Pharma Cash-to-Debt Chart

Orion Pharma Annual Data

Trend

Dec13

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash-to-Debt

Get a 7-Day Free Trial

0.01

0.08

0.03

0.01

Orion Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															0.10	0.02	0.01	0.01	0.01

Competitive Comparison of Orion Pharma's Cash-to-Debt

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Pharma's Cash-to-Debt Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Cash-to-Debt falls into.

Orion Pharma Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Orion Pharma's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	168.787	/	(1062.228	+	20834.406)
	=	0.01

Orion Pharma's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	176.223	/	(3477.45	+	18787.524)
	=	0.01

Orion Pharma (DHA:ORIONPHARM) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Orion Pharma Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Pharma (DHA:ORIONPHARM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208

Website

https://www.orionpharmabd.com

Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma (DHA:ORIONPHARM) Headlines

No Headlines